While deal value decreased by 7% from 2019 to 2020, total deal count increased by 10% as more investors looked to add-on to existing platforms rather than seeking out new, larger targets of interest, the American Health Law Association reports. This increased deal activity, which saw a particularly large surge in the fourth quarter of 2020, has continued throughout the first half of 2021. The article examines PE health care deal activity pre- and post- emergence of COVID in the United States and key drivers in PE health care investment throughout this time period. Read more.
Private Equity and Health Care Investments: How Has COVID-19 Impacted Deal Flow?
